对心脏脏综合征的基于设备的治疗方法的进展
Michele L Esposito1, Ryan Moore2
1Division of Cardiology, Medical University of South Carolina, Charleston, South Carolina.
Current opinion in cardiology
|February 25, 2025
概括
新的设备为患有心力衰竭和心综合征的患者提供了希望,这些患者抵抗利尿剂. 这些创新疗法旨在改善功能,减少住院时间,从而有可能改善治疗结果.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 医疗器械 医疗器械
背景情况:
- 利尿剂耐药性是去补偿性心力衰竭和心综合征的一个重大挑战.
- 这种抗药性导致复杂的临床决策和较差的患者预后.
- 基于设备的疗法正在成为管理这些复杂病例的有希望的替代方案.
研究的目的:
- 审查在心脏脏综合征中基于设备的治疗方法的发展证据.
- 为心力衰竭患者突出创新的治疗方案与尿素耐药.
主要方法:
- 根据作用机制对新兴设备技术的分类.
- 根据它们的功能角色,描述"推进器"",拉动器"和"流体转移器".
主要成果:
- "推进器"可以增强脏动脉的血液流动和 perfusion.
- "Pullers"降低静脉压力,减少脏后负荷.
- "流体转移者"利用淋巴系统进行间歇性脱血.
结论:
- 早期的临床研究表明,这些新型设备具有前景.
- 随机对照试验是必要的,以验证它们在心力衰竭患者中的有效性.
- 未来与药理疗法的整合可能会减少住院治疗并改善死亡率.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
370
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
370
01:22Heart Failure Drugs: Diuretics
332
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
332
01:25Antihypertensive Drugs: Direct Renin Inhibitors
469
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
469
01:33Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
01:27Dialysis
249
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
249
01:11Renal Failure: Dose Adjustments
54
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
54